Screens and tests for NPS Dr Paul Smith Consultant Clinical Scientist and Forensic Toxicologist

Slides:



Advertisements
Similar presentations
Body packing and stuffing First detected case in Lithuania
Advertisements

Dr Paul Dargan & Dr David Wood Consultant Clinical Toxicologists Guy’s and St Thomas’ NHS Foundation Trust London, UK Monitoring Drug Emergencies How and.
1 New drugs coming our way - - what are they and how do we detect them? Leslie A King UK Focal Point on Drugs EMCDDA Conference: Identifying Europe’s information.
DRUGS ACTION “New Psychoactive Substances”. & Overdose Training
Synthetic marijuana and the latest trends in substance abuse Nancy V Rodway MD MS MPH Medical Director Occupational Services and Employee Health Lake Health.
Laboratory Challenges in Clinical Toxicology of Pain Management By Michael (Rusty) Nicar & Marc McCain Clinical Tandem Mass Spectrometry: Cutting Edge.
Prescription Drug Abuse And The Toxicology Of Medication Monitoring
NEW DRUGS OF ABUSE: BATH SALTS AND SYNTHETIC CANNABINOIDS Bruce D. Anderson, PharmD, DABAT Director of Operations Associate Professor University of Maryland.
Synthetic Drugs of Abuse: ‘Spice,’ ‘K2’ and ‘Bath Salts’ Erik Gunderson, MD Assistant Professor Department of Psychiatry and Neurobehavioral Sciences and.
Synthetic Drugs of Abuse: ‘Spice,’ ‘K2’ and ‘Bath Salts’ Side effects and Long term consequences Willie A. Hamilton, BC-FNP Board Certified in Sports Medicine.
SYNTHETIC CANNABINOIDS Shelley A. Holmer MD Duke University School of Medicine ©AMSP 2013 © AMSP
Online Sales and Use of Synthetic Cannabinoids Preliminary findings from a Norwegian study Ola Røed Bilgrei Anne Line Bretteville-Jensen SIRUS.
Dr Richard Stevenson. Confusing terminology “Designer Drugs” “Bath Salts” “Legal Highs” “Psychoactive drugs, newly available in the UK, which are not.
Overview of Drug Testing Process
Designer Drugs Adverse Effects of Spice and Bath Salts.
Designer Drugs – What Drug Court Practitioners Need to Know
Designer Drugs – What You Need to Know The Fundamentals By: Paul L. Cary Toxicology Laboratory University of Missouri.
Bath Salts. INTRODUCTION / OVERVIEW The Florida Department of Law Enforcement (FDLE) is providing the following situational awareness brief addressing.
History 2010 Law enforcement first started hearing about “Synthetic cocaine” Not actually cocaine, but Mephedrone At that time, very little was known Illegal.
Seth Cooper Jason Kennedy Kansas City Police Crimelab Synthetic Cannabinoids and Bath Salts.
 Why are we here? › Synthetic drugs are a serious health and safety problem that needs to be immediately addressed. These drugs are readily available.
JOSEPH DE SOTO MD, PHD, FAIC Drugs of Abuse. Overview At any given month about 10% of the population is using drugs which are considered illegal. These.
New Psychoactive Substances A BRIEF INSIGHT BY LEIGH WESTMORE.
L.O- To learn about different types of illegal drugs.
Drink and Drug Driving Future Challenges Andy Bodkin Centre for Applied Science and Technology 19 th May 2015.
Novel Psychoactive Substances
8 th Grade Illegal Drugs Stimulants, Depressants, and Narcotics.
Did he get injury? Dr. Law chi yin PYNEH. One Saturday afternoon young man age 32 Sent to AED by ambulance Fixed by spinal board and neck collar Claimed.
Synthetic Marijuana and Bath Salts Nina Hancock, LMFT Therapist at the Adventure Program 1003 North Broadway Johnson City, TN
Synthetic Drugs. Synthetic Cannabinoids Contain dried, shredded plant material. “Spice” is sprayed onto the plant material. Also known as “K2”, “Yucatan.
Practical guide to the use of urine drug screens in primary care
Forensic Drug Analysis 60 % of Forensics Lab work is drugs 85-90% of all Criminal Cases involve drugs.
Clinical Experience of Novel Psychoactive Substances Dr Richard Stevenson.
Dr. Paul Skett Forensic Pharmacologist Glasgow Expert Witness Service
SYNTHETIC CANNABINOIDS Shelley A. Holmer MD Duke University School of Medicine ©AMSP 2013 © AMSP
IOWA’S EMERGING DRUG TRENDS 2012 Region VII – VPPPA Conference.
Broward Quick Check September 2012 Drug Abuse Patterns and Trends Update James N. Hall, Epidemiologist Center for Applied Research on Substance Use and.
April 1, 2013 Do Now: In your notebooks, write out one question you have about the midterm material. Topics covered include toxicology and toxicity, controlled.
NPS Symposium Charles Berry House Tuesday November 3 rd 2015 Dr Rob Hampton
Emergency Management of Drug Overdose
NPS and Importance of Information Sharing Dr Richard Stevenson A&E Department, Glasgow Royal Infirmary Dr Hazel Torrance Forensic Medicine and Science.
Annual report 2012: the state of the drugs problem in Europe Name, date.
Drug Impaired Driving: A Toxicologist Perspective Bruce A. Goldberger, Ph.D. Division of Forensic Medicine Departments of Pathology and Psychiatry University.
K2 Spice.  POISON sprayed on leaves  K2 or Spice is a mixture of herbs, spices or shredded plant material. “Fake Weed” that resembles potpourri. 
Molly – a newly popular club drug. “Molly” may refer to 2 different drugs  1. MMDA, the main constituent of Ecstasy  2. TFMPP, a non-controlled synthetic.
Drugs of Abuse Service: Urine and oral fluid testing Dr Paul Cawood Toxicology, Clinical Biochemistry, RIE GP-Laboratory Medicine Update Meeting 11 th.
Trends in Drug Use.
Poly-substance Impaired Drivers
PACIFIC SCHOOL OF ENGINEERING
DR. Fernando Caudevilla Energy control (ABD)
New Psychoactive Substances (NPS) in Pooled Urine and Wastewater:
Prescription and illicit psychoactive drugs in oral fluid—LC–MS/MS method development and analysis of samples from Brazilian drivers  Ivomar Zancanaro,
Prescription and illicit psychoactive drugs in oral fluid—LC–MS/MS method development and analysis of samples from Brazilian drivers  Ivomar Zancanaro,
Samantha Palmer Emery House Jillian Emerson
Drugs.
Chapter 9 -- Drugs Drug: a substance that is used to produce physiological or psychological effects. Drug abuse – a brief history In the 1960s, the main.
Rohypnol Bellik Bolkeim Period.1.
Laboratory Aspects of Monitoring Medication Compliance Karla J
History of Drugs and the Legislation made to control them
Controlled substance compliance
Dr. Abdulmonem Al-Hayani MBChB, DipFMS(Lon), PhD(Aber)
Adverse Effects of Spice and Bath Salts
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Chemistry: Reactions in medicine
Drugs of Abuse Service: Urine and oral fluid testing Dr Paul Cawood Toxicology, Clinical Biochemistry, RIE GP-Laboratory Medicine Update Meeting 11th.
Poison- Murder, Accidental Overdoses, and Drug Offences
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Presentation transcript:

Screens and tests for NPS Dr Paul Smith Consultant Clinical Scientist and Forensic Toxicologist

Screens and tests for NPS Where we are now Scope for the future Potential for treatment / antidotes Opportunities in LLR

‘£10 legal high made me parade naked through Tesco’

NPS Many different terms - legal highs, designer drugs, research chemicals Stimulant pills / powders Herbal smoking mixes Cheap Readily available Increasing prevalence Perception that legal = safe Many now illegal Cases of acute toxicity and death

EMCDDA Report 2015

Drug seizures

Immunoassay and GC-MS Uses commercial libraries of drugs and metabolites ~1000 drugs and metabolites Custom the library

Drug screen by LC-MS/MS NOT able to detect synthetic cannabinoids DRUG 1 4-MEC 2 6-MAM 3 Amphetamine 4 Benzoylecgonine 5 Buprenorphine 6 Cocaethylene 7 Cocaine 8 Codeine 9 Diazepam 10 Dihydrocodeine 11 EDDP 12 Gabapentin 13 MDA 14 MDEA 15 MDMA 16 Mephedrone (MCAT) 17 Methadone 18 Methamphetamine 19 Methylecgonine 20 Midazolam 21 Morphine 22 Nitrazepam 23 Norbuprenorphine 24 Nordiazepam 25 Oxazepam 26 Oxycodone 27 Oxymorphone 28 Pholcodine 29 Pregabalin 30 Temazepam 31 THC-COOH 32 Zopiclone

NPS screen by LC-MS/MS (post-mortem) 4-Fluoroamphetamine Paramethoxyamphetamine (PMA) Paramethoxymethamphetamine (PMMA) 4-Methylthioamphetamine (4-MTA) Methiopropamine Cathinone Cathine Methcathinone Flephedrone (4-fluoromethcathinone) Mephedrone (4-methylmethcathinone) 4-MEC (4-methylethcathinone) Methedrone (4-methoxymethcathinone) Benzedrone Methylone (beta-keto MDA) Ethylone (beta-keto MDMA) Butylone Clephedrone (4-chloromethcathinone) Benzylpiperazine (BZP) Trifluoromethylphenylpiperazine (TFMPP) 3-Chlorophenylpiperazine (MCPP) 2-Aminoindane Methylenedioxyaminoindane (MDAI) 5-Aminopropylindane (5API) Alpha-methyltryptamine (AMT) 5-Iodoaminoindane (5IAI) Methylenedioxypyrovalerone (MDPV) 5-APB / 6-APB Naphyrone Propylhexedrine Methoxetamine MBDB DOM DOET DOB Diclofensine Dimethocaine Desoxypipradol Ethylphenidate Etizolam Phenazepam NOT able to detect synthetic cannabinoids

Herbal products containing synthetic cannabinoids Black Mamba-type products are usually sold as herbal prep- arations containing inert herbal material (leaf etc.) saturated with synthetic cann- abinoids (SCs). The pure SC powder can also be bought online.

1 st generation synthetic cannabinoids John W. Huffman, Ph.D, Over 400 JWH compounds “I always had a hunch that someday somebody would say: ‘Hey, let’s try smoking them.’ And lo and behold, that’s what happened.”

2 nd generation synthetic cannabinoids

3 rd generation synthetic cannabinoids

High resolution mass spectrometry Expensive equipment Specialist analysis Targeted and non- targeted screens High resolution as opposed to nominal mass (e.g not 271) Full scan mode Capable of retrospective compound searching

Clinical cases CaseHistory Synthetic cannabinoid detectedOther drugs detected 1Extreme agitation in a psychiatric patient 5F-PB-22None 2 Prisoner found collapsed and fitting. History of black mamba use. 5F-AKB-48, 5F-PB-22, MDMB-CHMICA Mirtazapine, propofol, lignocaine, atracurium

Post mortem cases CaseHistory Synthetic cannabinoid detectedOther drugs detected 1Mixed drug intake5F-AKB-48 Diazepam, heroin, cocaine, mirtazapine, propranolol, phenytoin, olanzapine 2Collapse5F-AKB-48, 5F-PB-22None 3Agitation5F-AKB-48, 5F-PB-23Amphetamine, cocaine 4Agitation5F-AKB-48, MDMB-CHMICA Heroin, buprenorphine, promethazine, procyclidine, diazpeam, gabapentin, lorazepam 5Heroin and mixed drugs5F-AKB-48, 5F-PB-22Cocaine, heroin, amphetamine, 6Hanging5F-AKB-48, 5F-PB-23Ethanol 7Death in custody5F-AKB-48, MDMB-CHMICADiazepam, mirtazapine, amitriptyline, heroin, cocaine, thc 8Dead on sofa 5F-AKB-48, MDMB-CHMICA, THJ2201Morphine, lorazepam, 2 aminoindane 9DrowningAKB-48THC, promethazine 10Assault5F-AKB-48, 5F-PB-22THC, papracetamol 11UnknownJWH-018MDPV, ethanol 12Prison deathMDMB-CHMICADihydrocodeine 13Prison deathMDMB-CHMICAMirtazapine, alfentanil, prochlorperazine, lignocaine, atracurium, 14UnknownMDMB-CHMICAIbuprofen

Signs and symptoms CNS: agitation, tremor, anxiety, confusion, somnolence, syncope, hallucinations, changes in perception, acute psychosis, nystagmus, convulsions and coma. Cardiac: tachycardia, hypertension, chest pain, palpitations, ECG changes. Renal: acute kidney injury. Muscular: hypertonia, myoclonus, muscle jerking and myalgia. Other: cold extremities, dry mouth, dyspnoea, mydriasis, vomiting and hypokalaemia. Long term effect: no documented evidence

Treatment Supportive – NO ANTIDOTE Observe patient ECG U&Es, creatinine and CK Agitation and delirium - diazepam, haloperidol Convulsions - diazepam

Rapid drug test kit NPT devices do exist but are limited to specific compounds  JWH-018  JWH-073

Opportunities in LLR Funding required for equipment to increase understanding and recognition of NPS including synthetic cannabinoids Epidemiology studies Patient monitoring Potential to assist treatment decisions

K2/Spice